ArticleJournal of viral hepatitis2020

Eight weeks of sofosbuvir/velpatasvir for genotype 3 hepatitis C in previously untreated patients with significant (F2/3) fibrosis.

Alison Boyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.